ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of MR-conditional labeling for ...

St. Jude Medical Inc. STJ recently announced that the company has received approval of MR-conditional labeling for the company’s Penta 5-column paddle lead for spinal cord stimulation (SCS) therapy.

2020 FEB 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health Policy and Law Daily-- Investigators publish new report on Health and Medicine - Neurology. According to news reporting ...

New MR-conditional labeling for the Penta paddle lead ensures patients in need of future MRIs can access the industry’s broadest paddle lead to support the treatment of chronic pain St. Jude Medical, ...

St. Jude Medical Inc.STJ recently announced that the company has received approval of MR-conditional labeling for the company's Penta 5-column paddle lead for spinal cord stimulation (SCS) therapy. St ...